Medicinal chemistry approaches to the inhibition of dipeptidyl peptidase-4 for the treatment of type 2 diabetes

This publication has 113 references indexed in Scilit:

• (3R)-3-Amino-4-(2,4,5-trifluorophenyl)-N-{4-[6-(2-methoxyethoxy)benzothiazol-2-yl]tetrahydropyran-4-yl}butanamide as a potent dipeptidyl peptidase IV inhibitor for the treatment of type 2 diabetes
  Bioorganic & Medicinal Chemistry Letters, 2008
• 3,5-Dihydro-imidazo[4,5-d]pyridazin-4-ones: A class of potent DPP-4 inhibitors
  Bioorganic & Medicinal Chemistry Letters, 2008
• Potent non-nitrile dipeptidic dipeptidyl peptidase IV inhibitors
  Bioorganic & Medicinal Chemistry Letters, 2007
• 4-Arylcyclohexylalanine analogs as potent, selective, and orally active inhibitors of dipeptidyl peptidase IV
  Bioorganic & Medicinal Chemistry Letters, 2007
• Rational design of a novel, potent, and orally bioavailable cyclohexylamine DPP-4 inhibitor by application of molecular modeling and X-ray crystallography of sitagliptin
  Bioorganic & Medicinal Chemistry Letters, 2007
• New fluorinated pyrrolidine and azetidine amides as dipeptidyl peptidase IV inhibitors
  Bioorganic & Medicinal Chemistry Letters, 2005
• Diprolyl nitriles as potent dipeptidyl peptidase IV inhibitors
  Bioorganic & Medicinal Chemistry Letters, 2005
• 1-((S)-γ-Substituted prolyl)-(S)-2-cyanopyrrolidine as a novel series of highly potent DPP-IV inhibitors
  Bioorganic & Medicinal Chemistry Letters, 2005
• Mechanism of proline-specific proteinases: (I) substrate specificity of dipeptidyl peptidase IV from pig kidney and proline-specific endopeptidase from Flavobacterium meningosepticum
  Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology, 1988
• Truncated glucagon‐like peptide I, an insulin‐releasing hormone from the distal gut
  FEBS Letters, 1987